M'Hamed Bentourkia

Prof. M'Hamed Bentourkia

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2007 in PET Clinics
Verified
Journal Article
Closed access
MBM'Hamed Bentourkia
M'Hamed Bentourkia
Habib ZaidiHabib Zaidi
Habib Zaidi

1 April 2009 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Closed access
PDF file
MBM'Hamed Bentourkia
M'Hamed Bentourkia
STSébastien Tremblay
Sébastien Tremblay
FPFabien Pifferi
Fabien Pifferi
JRJacques Rousseau
Jacques Rousseau
RLRoger Lecomte
Roger Lecomte
SCStephen Cunnane
Stephen Cunnane
Normally, the brain's fuel is glucose, but during fasting it increasingly relies on ketones (β-hydroxybutyrate, acetoacetate, and acetone) produced in liver mitochondria from fatty acid β-oxidation. Although moderately raised blood ketones produced on a very high fat ketogenic diet have important clinical effects on the brain, including reducing seizures, ketone metabolism by the brain is still poorly understood. The aim of the present work was to assess brain uptake of carbon-11-labeled acetoacetate (11C-acetoacetate) by positron emission tomography (PET) imaging in the intact, living rat. To vary plasma ketones, we used three dietary conditions: high carbohydrate control diet (low plasma ketones), fat-rich ketogenic diet (raised plasma ketones), and 48-h fasting (raised plasma ketones). 11C-acetoacetate metabolism was measured in the brain, heart, and tissue in the mouth area. Using 11C-acetoacetate and small animal PET imaging, we have noninvasively quantified an approximately seven- to eightfold enhanced brain uptake of ketones on a ketogenic diet or during fasting. This opens up an opportunity to study brain ketone metabolism in humans.

1 June 2016 in Brain and Development
Verified
Journal Article
Closed access
MFMarie Farmer
Marie Farmer
BEBernard Echenne
Bernard Echenne
MBM'Hamed Bentourkia
M'Hamed Bentourkia

1 October 2003
Verified
Journal Article
Closed access
ECEtienne Croteau
Etienne Croteau
FBFrancois Benard
Francois Benard
JCJules Cadorette
Jules Cadorette
MGMarie-Eve Gauthier
Marie-Eve Gauthier
AAAntonio Aliaga
Antonio Aliaga
RLRoger Lecomte
Roger Lecomte

22 January 2024 in Antioxidants
Verified
Journal Article
Open access
PDF file
NZNada Zoubdane
Nada Zoubdane
RARedha-Alla Abdo
Redha-Alla Abdo
MNMichel TS NGUYEN
Michel TS NGUYEN
MBM'Hamed Bentourkia
M'Hamed Bentourkia
ETEric E. Turcotte
Eric E. Turcotte
Abdelouahed KhalilAbdelouahed Khalil
Abdelouahed Khalil
Aging is an important risk factor for cardiovascular diseases and convincing data have shown that chronic low-grade inflammation, which develops with advanced age, contributes significantly to cardiovascular risk. The present study aimed to use 18F-FDG/18F-NaF-PET/CT imaging to, respectively, gauge arterial inflammation and microcalcification in a healthy elderly population and to assess the potential benefits of a tyrosol- and hydroxytyrosol-rich diet on these two markers of atherosclerotic plaque fragility. Eleven healthy participants (mean age 75 ± 5.67 years) were supplemented for 6 months with high polyphenol-rich extra virgin olive oil (HP-EVOO), extra virgin olive oil (EVOO), or refined olive oil (ROO). The participants underwent PET/CT imaging with 18F-FDG and 18F-NaF radiotracers at baseline and after 6 months. 18F-FDG and 18F-NaF uptakes were quantified using standardized uptake values (SUV) and were categorized based on artery calcification and olive oil type. A total of 324 slices of the aortas of the imaged participants were analyzed for arterial inflammation and 327 slices were analyzed for microcalcification. 18F-FDG uptake was significantly higher in the non-calcified segments than in the calcified segments (SUVmax = 2.70 ± 0.62 and SUVmax = 2.54 ± 0.44, respectively, p < 0.042). Conversely, the non-calcified segments displayed significantly lower 18F-NaF uptake than the calcified segments (SUVmax = 1.90 ± 0.37 and 2.09 ± 0.24, respectively, p < 0.0001). The 6-month supplementation with HP-EVOO induced a significant reduction in 18F-FDG uptake in both the non-calcified (2.93 ± 0.23 to 2.75 ± 0.38, p < 0.004) and calcified segments of the aortas (2.25 ± 0.29 to 2.15 ± 0.19, p < 0.02). 18F-NaF uptake was also significantly lower in patients supplemented with HP-EVOO (SUVmax = 1.98 ± 0.33 at baseline compared to 1.85 ± 0.28, after the 6-month supplementation, p < 0.004), whereas no significant effect was observed with EVOO. Conversely, participants supplemented with ROO displayed a significant increase in 18F-NaF uptake (SUVmax = 1.78 ± 0.34 to 1.95 ± 0.34, p < 0.0001). The present study confirmed that a phenolic-compound-rich diet reduces both arterial inflammation and atherosclerotic lesion microcalcification and demonstrated that 18F-FDG/18F-NaF-PET/CT imaging is a valuable approach for assessing age-related arterial damage.